A blood-based prognostic biomarker in IBD.

Daniele BiasciJames C LeeNurulamin M NoorDiana R PombalMonica HouNina LewisTariq AhmadAilsa HartMiles ParkesEoin F McKinneyPaul A LyonsKenneth G C Smith

Published in: Gut (2019)

This is the first validated prognostic biomarker that can predict prognosis in newly diagnosed patients with IBD and represents a step towards personalised therapy.

Keyphrases

newly diagnosed
cell therapy